BG102771A - Нови диарилметилиденфуранови производни, метод за тяхното получаване и използването им като лекарствени средства - Google Patents

Нови диарилметилиденфуранови производни, метод за тяхното получаване и използването им като лекарствени средства

Info

Publication number
BG102771A
BG102771A BG102771A BG10277198A BG102771A BG 102771 A BG102771 A BG 102771A BG 102771 A BG102771 A BG 102771A BG 10277198 A BG10277198 A BG 10277198A BG 102771 A BG102771 A BG 102771A
Authority
BG
Bulgaria
Prior art keywords
diarylmethylidenfuran
utilization
derivatives
preparation
medicamentous forms
Prior art date
Application number
BG102771A
Other languages
English (en)
Other versions
BG62808B1 (bg
Inventor
Eric Nicolai
Jean-Marie Teulon
Original Assignee
Laboratoires Upsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Upsa filed Critical Laboratoires Upsa
Publication of BG102771A publication Critical patent/BG102771A/bg
Publication of BG62808B1 publication Critical patent/BG62808B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Изобретението се отнася до диарилметилиденфуранови производни с формула в която значенията на заместителите са посоченив описанието, и до тяхното използване като лекарствени средства, по-специално като противовъзпалителни и аналгетични средства.
BG102771A 1996-04-04 1998-09-16 Нови диарилметилиденфуранови производни, метод за тяхнотополучаване и използването им като лекарствени средства BG62808B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9604236A FR2747123B1 (fr) 1996-04-04 1996-04-04 Nouveaux derives diarylmethylidene tetrahydrofurane, leurs procedes de preparation, et leurs utilisations en therapeutique
FR9607922A FR2747124B1 (fr) 1996-04-04 1996-06-26 Nouveaux derives diarylmethylidene furaniques, leurs procedes de preparation et leurs utilisations en therapeutique
PCT/FR1997/000602 WO1997037984A1 (fr) 1996-04-04 1997-04-03 Nouveaux derives diarylmethylidene furaniques, leurs procedes de preparation et leurs utilisations en therapeutique

Publications (2)

Publication Number Publication Date
BG102771A true BG102771A (bg) 1999-06-30
BG62808B1 BG62808B1 (bg) 2000-08-31

Family

ID=9490907

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102771A BG62808B1 (bg) 1996-04-04 1998-09-16 Нови диарилметилиденфуранови производни, метод за тяхнотополучаване и използването им като лекарствени средства

Country Status (28)

Country Link
EP (1) EP0891345B1 (bg)
JP (1) JP2000508638A (bg)
KR (1) KR20000005146A (bg)
CN (1) CN1215396A (bg)
AR (1) AR006539A1 (bg)
AT (1) ATE204268T1 (bg)
AU (1) AU717146B2 (bg)
BG (1) BG62808B1 (bg)
BR (1) BR9708510A (bg)
CA (1) CA2248949A1 (bg)
CZ (1) CZ318898A3 (bg)
DE (1) DE69706157T2 (bg)
DK (1) DK0891345T3 (bg)
EE (1) EE03687B1 (bg)
ES (1) ES2162678T3 (bg)
FR (2) FR2747123B1 (bg)
GE (1) GEP20032924B (bg)
IL (1) IL126105A (bg)
NO (1) NO984624L (bg)
NZ (1) NZ331672A (bg)
PL (1) PL329213A1 (bg)
PT (1) PT891345E (bg)
RU (1) RU2189979C2 (bg)
SI (1) SI0891345T1 (bg)
SK (1) SK283292B6 (bg)
TW (1) TW353660B (bg)
WO (1) WO1997037984A1 (bg)
ZA (1) ZA972894B (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180651B1 (en) * 1996-04-04 2001-01-30 Bristol-Myers Squibb Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
US6026814A (en) 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
WO1998043966A1 (en) * 1997-04-02 1998-10-08 Merck Frosst Canada & Co. Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors
FR2775477B1 (fr) * 1998-02-27 2000-05-19 Union Pharma Scient Appl Nouveaux derives diarylmethylene heterocycliques, leurs procedes de preparation et leurs utilisations en therapeutique
CN1106392C (zh) * 2000-10-24 2003-04-23 中国科学院上海有机化学研究所 一种β位不含取代基的丁烯酸内酯及其合成的方法
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
WO2004041217A2 (en) * 2002-11-05 2004-05-21 Magnachem International Laboratories, Inc. Synthetic lactone formulations and method of use
WO2004087644A1 (en) * 2003-03-31 2004-10-14 Council Of Scientific And Industrial Research Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
US8779168B2 (en) * 2010-12-16 2014-07-15 Transitions Optical, Inc. Lactone compounds and materials made therefrom
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0679157B1 (en) * 1993-01-15 1997-11-19 G.D. Searle & Co. Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge

Also Published As

Publication number Publication date
CZ318898A3 (cs) 1999-01-13
RU2189979C2 (ru) 2002-09-27
EE03687B1 (et) 2002-04-15
ZA972894B (en) 1997-11-04
AU717146B2 (en) 2000-03-16
AR006539A1 (es) 1999-09-08
KR20000005146A (ko) 2000-01-25
NO984624L (no) 1998-11-30
CA2248949A1 (fr) 1997-10-16
AU2393397A (en) 1997-10-29
NZ331672A (en) 2000-02-28
PT891345E (pt) 2002-02-28
FR2747124B1 (fr) 1998-06-26
EE9800333A (et) 1999-04-15
DE69706157T2 (de) 2002-04-11
TW353660B (en) 1999-03-01
SK137598A3 (en) 1999-02-11
IL126105A (en) 2001-08-26
EP0891345A1 (fr) 1999-01-20
FR2747124A1 (fr) 1997-10-10
DK0891345T3 (da) 2001-12-03
BR9708510A (pt) 1999-08-03
PL329213A1 (en) 1999-03-15
CN1215396A (zh) 1999-04-28
IL126105A0 (en) 1999-05-09
GEP20032924B (en) 2003-03-25
SI0891345T1 (en) 2002-02-28
ES2162678T3 (es) 2002-01-01
NO984624D0 (no) 1998-10-02
DE69706157D1 (de) 2001-09-20
FR2747123A1 (fr) 1997-10-10
FR2747123B1 (fr) 1998-06-26
WO1997037984A1 (fr) 1997-10-16
JP2000508638A (ja) 2000-07-11
BG62808B1 (bg) 2000-08-31
SK283292B6 (sk) 2003-05-02
EP0891345B1 (fr) 2001-08-16
ATE204268T1 (de) 2001-09-15

Similar Documents

Publication Publication Date Title
BG101132A (bg) Пиридоанилирани тиенилови и фуранилови оксазолидинони
BG101193A (bg) Нови заместени оксазолидинони
BG101139A (bg) Съдържащи хетероатоми циклопентанопиридилоксазолидинони
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
MY131298A (en) 5-heteroyl indole derivatives
BG101131A (bg) 2-оксо- и 2-тио-1,2-дихидрохинолинилоксазолидинони
BG103664A (bg) Фармацевтични форми, съдържащи амоксицилин и клавуланат
BG102616A (bg) Заместени аза- и диазациклохептанови и циклооктанови производни и използването им
AU3495395A (en) Cyclic cs-1 peptidomimetics, compositions and methods of using the same
LU91758I9 (bg)
IS4785A (is) Tríazól afleiður, gagnlegar í meðhöndlun
CA2160966A1 (fr) Derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUP9701264A3 (en) Aminoacid derivatives, process for producing them and pharmaceutical compositions containing them
UA42795C2 (uk) Протизапальний засіб для зовнішнього застосування, що містить німесулід, і спосіб його одержання
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU2675095A (en) Indol derivatives useful for the treatment of migraine, composition and utilization
BG103914A (bg) Фармацевтичен състав с продължително освобождаване и неговото използаве
PL319784A1 (en) Keratinocytic growth factor analoques
HUP9700926A3 (en) Vitamine d3 analogues, process for producing them and pharmaceutial compositions containing the same
BG102362A (bg) Нови производни на аминокиселини, тяхното получаване и използване
BG102589A (bg) 3-азетидинилалкилпиперидини или - пиролидини катотахикининови антагонисти
BG102771A (bg) Нови диарилметилиденфуранови производни, метод за тяхното получаване и използването им като лекарствени средства
BG102395A (bg) Нови фениламидинови производни, метод за тяхното получаване и приложението им като лекарствени средства
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
GB2288183B (en) Composition and method of preparing microemulsion blends